← All trials
NCT06992687
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 1, 2024
- Primary completion
- Sep 30, 2025
- Completion date
- Nov 30, 2025
- First posted
- May 28, 2025
- Last posted
- May 28, 2025
- Enrollment
- 30
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Zhejiang Huahai Pharmaceutical Co., Ltd.Lead sponsor
- Central South UniversityCollaborator
- Chinese Academy of Medical SciencesCollaborator
- Peking UniversityCollaborator
- Harbin Medical UniversityCollaborator
- Huazhong University of Science and TechnologyCollaborator
- Shandong UniversityCollaborator
- Nanjing UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.